Bianca Gimondo

Recce Pharmaceuticals (ASX:RCE) is accelerating the development of its synthetic class of potent anti-infectives, and its new Family 4 patent has been granted for use in Australia in FY23.

Tennant Minerals (ASX:TMS) has struck high-grade copper-gold intersections from diamond drilling at the Bluebird discovery zone within its Barkly project in the Northern Territory.

Barton Gold (ASX:BGD) has identified multiple broad and high-grade intersections outside the current mineral resource estimate (MRE) at the Tunkillia 223 deposit in SA.

YPB Group (ASX:YPB) has secured $2 million through a placement to pay off debts, develop its tech, market products, and support ongoing business operations.

Bio-Gene Technology (ASX:BGT) has been granted a new US patent to expand the protection of its insecticide products.

Far East Gold (ASX:FEG) has struck visible gold and electrum during a phase two resource delineation drill program at its Woyla project in Indonesia

Provaris Energy (ASX:PV1) continues to advance development work for its Tiwi H2 hydrogen project in Australia, with cost estimates and solar farm design on track for April this year.

Intellectual property specialist IPH (ASX:IPH) has been hit by a potential cyber security breach at its head office and two member firms in Australia.

Telix Pharmaceuticals (TLX) has landed US FDA approval to image patients with metastatic prostate cancer with its Illuccix imaging agent.

Ausgold (ASX:AUC) has identified high-grade mineralisation in a new northern zone outside its current Katanning gold project ore reserve in WA.